Tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see Pharmacology: Pharmacodynamics under Actions for important information on the populations for which efficacy has been established).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
